The spring of 1997 was a significant time for theFood and Drug Administration (FDA). An overhaul of the Agency’s Good Manufacturing Processes (GMP) brought changes that had not been seen for a quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback